Price Alert

Rigel Pharmaceuticals Inc... (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

39.55

1.66 (4.38%)

At close: Aug 15, 2025, 3:38 PM

4.38% (1D)

Bid	39.51
Market Cap	709.49M
Revenue (ttm)	267.92M
Net Income (ttm)	97.82M
EPS (ttm)	5.43
PE Ratio (ttm)	7.28
Forward PE	9.86
Analyst	Hold

Ask	39.59
Volume	534,984
Avg. Volume (20D)	335,506
Open	38.02
Previous Close	37.89
Day's Range	37.50 - 39.68
52-Week Range	11.96 - 39.68
Beta	1.21

About RIGL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RIGL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RIGL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Rigel Pharmaceuticals has released their quartely earnings on Aug 5, 2025:

Revenue of $101.69M exceeds estimates by $26.6M, with 176.01% YoY growth.

EPS of 3.28 exceeds estimates by 1.65, with 5566.67% YoY growth.

Next Earnings Release

Rigel Pharmaceuticals Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+22.98%

Rigel Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription

3 months ago

+1.15%

RIGL stock has given up its prior gain. Rigel Pharmaceuticals shares were trading higher after the company reported Q1 financial results and beat its EPS and sales estimates.

News

1 day ago · seekingalpha.com

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Rigel's Q2 results were outstanding, with revenue nearly doubling and net income surging, driven by strong commercial momentum for TAVALISSE, GAVRETO, and REZLIDHIA. Management raised 2025 guidance, e...

1 week ago · zacks.com

Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy?

Rigel Pharmaceuticals (RIGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

6 days ago · zacks.com

Best Momentum Stock to Buy for August 8th

RIGL, APG and CLSK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 8, 2025.

6 days ago · zacks.com

5 Best Stocks With Relative Price Strength to Buy Right Now

LendingTree, RIGL, and others are standing out with strong relative price strength amid market volatility.

1 week ago · zacks.com

New Strong Buy Stocks for August 8th

INFU, RIGL, TROW, MITSY and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on August 8, 2025.

1 week ago · zacks.com

Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Rigel Pharmaceuticals, Inc. (RIGL) is looking like an interesting pick, as it just reached a key level of support. RIGL's 50-day simple moving average crossed above its 2...

1 week ago · zacks.com

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run?

Rigel (RIGL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

1 week ago · fool.com

Rigel (RIGL) Q2 Revenue Jumps 176%

1 week ago · seekingalpha.com

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants David A. Santos - Executive VP & Chief Commercial Officer Dean L.

1 week ago · zacks.com

Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $3.28 per share, beating the Zacks Consensus Estimate of $1.97 per share. This compares to a loss of $0.06 per share a year ago.

Load More News